| Jinhua Mingzhu
Pharmaceutical Corporation is a company of limited liability
and GMP certification enterprise (certificate no. Zhejiang
F0168、no. Zhejiang
H0387) set up in Feb. 2003, approved by Zhejiang Drug
Administration. The company now owns fixed capital RMB 28
million, and occupies floor area 30,000 square meters,
building area 8,000 square meters. It is provided with solid
preparation workshop, Chinese traditional medicine extraction
workshop and composite pharmaceutical product workshop. Also
it has the self-support import and export rights of commodity
and technique.
The product scope of company includes
Chinese medical preparation, pharmaceutical product and
bismuth salt.
The major pharmaceutical product is bismuth
salt, which includes basic bismuth nitrate, bismuth
subcarbonate, bismuth aluminate, bismuth subsalicylate,
bismuth subgallate, and lansoprazole, etc. These products are
now exported to Europe, America, Japan, Korea and Southeast
Asia, etc.
Baokang Refine Chemical Industry Plant
subordinated to our company is a manufacturer with more than
one decade processing experience of bismuth salt products. The
major products are bismuth oxide, bismuth nitrate and bismuth
oxychloride.
In China, we are the sole producer of
stilbene pallas capsule, which is the protected traditional
Chinese medicinal product. This is the new drug prepared by
pure Chinese medicine, based on the qi and blood theory in
Chinese medicine, and processed from angelica blood-enriching
soup in the way of extracting, processing and refining the
drug through modern hi-tech, added with pallas that can
nourish liver and tonify kidney, dispel pathogenic wind and
remove obstruction in the channels. Its function is to
invigorate qi and enrich blood, as well as to dispel
pathogenic wind and remove obstruction in the channels.
Our company sticks to the development
concept of continuous innovation, scientific management and
human-oriented. "Quality first, customer satisfied" is our
business principle. Honest and credible, we endeavor to
establish the cooperation relationship on a reciprocal basis
with dealers and agents, and expand the medicine market both
in China and abroad, with the service idea of "for customer's
success" in mind.
Our company sincerely invites the
agents that have certain market sales experience and
development force to deputize stilbene pallas capsule and
other new drugs in Chinese and overseas markets. Meanwhile, we
welcome talents to join us for the bright future for both.
|